Is it Safe and Cost Saving to Defer the CD4+ Cell Count Monitoring in Stable Patients on Art with More than 350 or 500 cells/μl?

BACKGROUND: CD4+ lymphocyte cell count represents the main immunological marker used to monitor HIV infection. However, frequent monitoring may be unnecessary, could cause anxiety to the patient as well as burdening healthcare with extra expenses. OBJECTIVES AND METHODS: A two-step retrospective (sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Celesia, Benedetto Maurizio, Marino, Andrea, del Vecchio, Rosa Fontana, Bruno, Roberto, Palermo, Filippo, Gussio, Maria, Nunnari, Giuseppe, Cacopardo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827605/
https://www.ncbi.nlm.nih.gov/pubmed/31700588
http://dx.doi.org/10.4084/MJHID.2019.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827605/
https://www.ncbi.nlm.nih.gov/pubmed/31700588
http://dx.doi.org/10.4084/MJHID.2019.063

Ejemplares similares